• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

- 缺乏(此处原文“-Deficient”表述不完整,推测可能是某种特定因子缺乏)的胸段肉瘤的细胞病理学特征:2例报告及文献复习

Cytopathological Features of -Deficient Thoracic Sarcoma: Report of 2 Cases and Review of the Literature.

作者信息

Takeda Maiko, Tani Yoko, Saijo Nobuhiko, Shimizu Shigeki, Taniguchi Yoshihiko, Otsuka Kenji, Nakao Keiko, Tamiya Akihiro, Okishio Kyoichi, Atagi Shinji, Ohbayashi Chiho, Kasai Takahiko

机构信息

National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan.

Osaka City University, Osaka, Japan.

出版信息

Int J Surg Pathol. 2020 Feb;28(1):109-114. doi: 10.1177/1066896919870866. Epub 2019 Aug 25.

DOI:10.1177/1066896919870866
PMID:31448657
Abstract

-deficient thoracic sarcoma (SMARCA4-DTS) is a recently described entity of thoracic sarcomas with an undifferentiated rhabdoid morphology and inactivation. Regardless of some reports about the histopathological findings so far, there have been only a few reports about the cytological features. In this article, we present the pathological features of 2 SMARCA4-DTS cases, including the cytological findings. Histopathologically, the tumor cells showed atypical loosely cohesive large epithelioid cells focally with geographic necrosis. Some cells were characterized by rhabdoid cells. Both patients showed intrathoracic masses with a history of smoking, and loss of SMARCA4 expression was confirmed with histopathological specimens. Immunohistochemically, tumor cells of both cases were at least focally positive for cytokeratin, CD34, CD99, synaptophysin, SOX2, and SALL4. In addition, tumor cells demonstrated significantly reduced expression of BRG1/SMARCA4 and SMARCA2. In conclusion, SMARCA4-DTS should be taken into consideration in the differential diagnosis of tumors with undifferentiated rhabdoid morphology involving the thoracic region.

摘要

SMARCA4缺陷型胸段肉瘤(SMARCA4-DTS)是一种最近描述的胸段肉瘤实体,具有未分化的横纹肌样形态和SMARCA4失活。尽管到目前为止有一些关于组织病理学发现的报道,但关于细胞学特征的报道却很少。在本文中,我们展示了2例SMARCA4-DTS病例的病理特征,包括细胞学发现。组织病理学上,肿瘤细胞表现为非典型的、松散聚集的大上皮样细胞,局灶性伴有地图状坏死。一些细胞具有横纹肌样细胞的特征。两名患者均表现为胸内肿块且有吸烟史,组织病理学标本证实存在SMARCA4表达缺失。免疫组化显示,两例病例的肿瘤细胞至少局灶性地对细胞角蛋白、CD34、CD99、突触素、SOX2和SALL4呈阳性。此外,肿瘤细胞显示BRG1/SMARCA4和SMARCA2的表达显著降低。总之,在鉴别诊断累及胸段区域的具有未分化横纹肌样形态的肿瘤时,应考虑SMARCA4-DTS。

相似文献

1
Cytopathological Features of -Deficient Thoracic Sarcoma: Report of 2 Cases and Review of the Literature.- 缺乏(此处原文“-Deficient”表述不完整,推测可能是某种特定因子缺乏)的胸段肉瘤的细胞病理学特征:2例报告及文献复习
Int J Surg Pathol. 2020 Feb;28(1):109-114. doi: 10.1177/1066896919870866. Epub 2019 Aug 25.
2
SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.SMARCA4缺陷型胸段肉瘤:一例病例报告及文献综述
Int J Surg Pathol. 2020 Feb;28(1):102-108. doi: 10.1177/1066896919865944. Epub 2019 Aug 5.
3
SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.SMARCA4 缺陷性胸肉瘤:30 例临床病理研究,重点在于其分类学和鉴别诊断。
Am J Surg Pathol. 2019 Apr;43(4):455-465. doi: 10.1097/PAS.0000000000001188.
4
Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.SMARCA4 缺陷性胸肉瘤的临床病理和分子特征,并与潜在相关实体进行比较。
Mod Pathol. 2017 Jun;30(6):797-809. doi: 10.1038/modpathol.2017.11. Epub 2017 Mar 3.
5
Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.SMARCA4缺陷型胸壁肉瘤的细胞学特征:一例报告并与其他SWI/SNF复合物缺陷型肿瘤的比较
Acta Cytol. 2018;62(5-6):456-462. doi: 10.1159/000493335. Epub 2018 Oct 4.
6
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.SMARCA4 缺陷性胸壁肉瘤:一种具有未分化横纹肌样形态和侵袭性行为的独特临床病理实体。
Mod Pathol. 2017 Oct;30(10):1422-1432. doi: 10.1038/modpathol.2017.61. Epub 2017 Jun 23.
7
SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources.SMARCA4 缺陷性胸壁肉瘤:病例报告及利用有限样本和资源进行诊断的相关见解。
Hum Pathol. 2017 Dec;70:92-97. doi: 10.1016/j.humpath.2017.05.024. Epub 2017 Jun 7.
8
Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.SMARCA4 缺陷性胸内肿瘤的细胞学:SMARCA4 缺陷性非小细胞肺癌与 SMARCA4 缺陷性胸内肉瘤的比较分析。
Acta Cytol. 2021;65(1):67-74. doi: 10.1159/000510323. Epub 2020 Aug 27.
9
Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.伴有神经节神经瘤和内生软骨瘤的胸椎SMARCA4缺陷未分化肿瘤:对SLC7A11和ARID1A表达的影响:一例报告
Diagn Pathol. 2022 Feb 12;17(1):29. doi: 10.1186/s13000-022-01205-8.
10
Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.SMARCA4 缺陷型胸壁肉瘤伴发严重骨骼相关事件的患者。
Lung Cancer. 2019 Jun;132:59-64. doi: 10.1016/j.lungcan.2019.03.029. Epub 2019 Apr 8.

引用本文的文献

1
Successful Diagnosis of a SMARCA4-Deficient Undifferentiated Tumor via Endobronchial Ultrasound-Guided Fine Needle Aspiration and Endobronchial Biopsies.通过支气管内超声引导下细针穿刺活检和支气管活检成功诊断SMARCA4缺陷型未分化肿瘤
Cureus. 2024 Dec 30;16(12):e76649. doi: 10.7759/cureus.76649. eCollection 2024 Dec.
2
Rapid Response to Penpulimab Combined With Anlotinib and Chemotherapy in a Thoracic SMARCA4-UT Without PD-L1 Expression: A Case Report and Review of Literature.培米普利单抗联合安罗替尼及化疗对无PD-L1表达的胸段SMARCA4-UT的快速反应:一例报告及文献复习
Clin Respir J. 2024 Dec;18(12):e70036. doi: 10.1111/crj.70036.
3
Fine-needle aspiration and effusion cytology of thoracic SMARCA4-deficient undifferentiated tumor and SMARCA4-deficient non-small cell lung carcinoma: A multi-institutional experience with 27 patients.
胸段SMARCA4缺陷型未分化肿瘤和SMARCA4缺陷型非小细胞肺癌的细针穿刺及积液细胞学检查:27例患者的多机构经验
Cancer Cytopathol. 2025 Jan;133(1):e22919. doi: 10.1002/cncy.22919. Epub 2024 Nov 18.
4
Imaging performance of thoracic SMARCA4-deficient undifferentiated tumor: a case report and literature review.胸段SMARCA4缺陷型未分化肿瘤的影像学表现:1例病例报告及文献复习
Transl Lung Cancer Res. 2024 Feb 29;13(2):443-452. doi: 10.21037/tlcr-23-822. Epub 2024 Feb 28.
5
Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology.诊断细胞学中胸 SMARCA4 缺陷型未分化肿瘤。
Cancer Cytopathol. 2023 Aug;131(8):526-534. doi: 10.1002/cncy.22709. Epub 2023 Jun 6.
6
Thoracic SMARCA4-deficient undifferentiated tumor.胸段SMARCA4缺陷型未分化肿瘤。
Discov Oncol. 2023 Apr 28;14(1):51. doi: 10.1007/s12672-023-00639-w.
7
The roles of the SWI/SNF complex in cancer.SWI/SNF复合物在癌症中的作用。
Cancer Cytopathol. 2023 Jul;131(7):410-414. doi: 10.1002/cncy.22691. Epub 2023 Apr 4.
8
Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure.病例报告:1例伴有呼吸衰竭的胸部SMARCA4缺陷型未分化肿瘤对免疫疗法的快速反应。
Front Oncol. 2022 Nov 1;12:1020875. doi: 10.3389/fonc.2022.1020875. eCollection 2022.
9
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.免疫荒漠型肿瘤微环境在胸内 SMARCA4 缺陷型未分化肿瘤中,免疫检查点抑制剂疗效有限。
Oncologist. 2022 Jun 8;27(6):501-511. doi: 10.1093/oncolo/oyac040.
10
Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study.41岁SMARCA4缺陷型胸壁肉瘤患者使用伊匹单抗和帕博利珠单抗的混合反应:一项跨学科病例研究
Case Rep Oncol. 2021 May 10;14(2):706-715. doi: 10.1159/000515416. eCollection 2021 May-Aug.